Skip to main content
Premium Trial:

Request an Annual Quote

Barcode Consortium Nets Over $6M from Ontario, New South Wales Funding

NEW YORK (GenomeWeb News) – The International Barcode of Life (iBOL) consortium, a Canadian-led venture aimed at developing a database that would help identify a species based on its DNA sequence, has gained roughly CDN$5.15 million (US$5.16M) in funding from the Ontario Ministry of Research and Innovation.
The consortium also recently received an approximately AUS$1.2 million (US$1.1M) pledge from the New South Wales Department of Primary Industries.
The iBOL consortium intends to raise CDN$150 million to develop a reference data set of five million DNA sequences, including 10 specimens per species, which will serve as a "global resource" that could help in “monitoring food purity, invasive or endangered species, industrial fouling, and environmental impact."
Along with the investment from the NSW’s DPI, the Australian Museum and the Botanic Gardens Trust in Sydney will work to help create an Australian node for the iBOL program.
The barcoding research iBOL is using also was funded in part by Genome Canada, Canada’s Natural Sciences and Engineering Research Council, the Canadian Foundation for Innovation, the Sloan Foundation, and the Moore Foundation, said OGI President and CEO Christian Burks.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.